FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|April 16, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 16, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 38.5% of total US population have received at least 1 dose
• 24.3% of total US population are fully vaccinated
• 24.3% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 31.5%
2. New Mexico: 31.3%
3. Alaska: 31.2%
4. Rhode Island: 30.9%
5. Connecticut: 30.4%
2. New Mexico: 31.3%
3. Alaska: 31.2%
4. Rhode Island: 30.9%
5. Connecticut: 30.4%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 31 524 464 confirmed cases
• 565 695 deaths
• 565 695 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 712 046
2. Texas: 2 844 303
3. Florida: 2 148 448
4. New York: 1 983 011
5. Illinois: 1 296 269
2. Texas: 2 844 303
3. Florida: 2 148 448
4. New York: 1 983 011
5. Illinois: 1 296 269
Deaths: California has the most deaths due to COVID-19 with 60 860 reported fatalities, followed by New York with 51 470, and Texas with 49 443.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 139 403 270 confirmed cases, 2 991 106 deaths, and 79 445 321 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
The Shift From Off-Label Use to On-Label Agitation Therapy
5